help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, F.
Right arrow Articles by Kamiyama, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, F.
Right arrow Articles by Kamiyama, K.

Endocrinology, Vol 117, 2081-2084, Copyright © 1985 by Endocrine Society

ARTICLES

Inhibitory effect of interferon on the production of insulin

F Shimizu, M Shimizu and K Kamiyama

Viral and bacterial infections may produce abnormalities in carbohydrate metabolism in normal subjects and profound changes in glucose homeostasis in insulin-dependent diabetics. Using an RIA with [125]porcine insulin, the effect of rat interferon (IFN) on the production/secretion of immunoreactive insulin (IRI) in cultured cells was investigated. We found that, after incubation of rat insulinoma cells with rat IFN, a decrease in the production of IRI was observed. The decrease correlated with the concentration of IFN and the length of the incubation. IFN also caused a decrease in the production/secretion of IRI from rat pancreatic beta-cells in primary culture. This IFN has all of the properties of IFN including species specificity, and the insulin inhibitory effect cannot be dissociated from the antiviral activity of IFN. These data suggest that one possible explanation for abnormalities in glucose metabolism associated with viral or bacterial infections is that virus-or bacteria-induced production of IFN may alter the concentration of insulin.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
E. A. Oral and M. Pietropaolo
Metabolism Lessons for Survival: When Adults and Children Are Not Alike.
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3763 - 3765.
[Full Text] [PDF]

Home page
 DiabetesHome page
D. Devendra, J. Jasinski, E. Melanitou, M. Nakayama, M. Li, B. Hensley, J. Paronen, H. Moriyama, D. Miao, G. S. Eisenbarth, et al.
Interferon-{alpha} as a Mediator of Polyinosinic:Polycytidylic Acid-Induced Type 1 Diabetes
Diabetes, September 1, 2005; 54(9): 2549 - 2556.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Pelegrin, J. C. Devedjian, C. Costa, J. Visa, G. Solanes, A. Pujol, G. Asins, A. Valera, and F. Bosch
Evidence from Transgenic Mice That Interferon-beta May Be Involved in the Onset of Diabetes Mellitus
J. Biol. Chem., May 15, 1998; 273(20): 12332 - 12340.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society